Literature DB >> 15710468

Relationship between alpha 7 nAChR and apoptosis in human lymphocytes.

María José De Rosa1, María Del Carmen Esandi, Andrés Garelli, Diego Rayes, Cecilia Bouzat.   

Abstract

The presence of nicotinic receptors (nAChRs) in blood cells has been demonstrated. However, little is known about their functional roles. We have detected mRNA of alpha7 nAChR in peripheral human lymphocytes and determined that its expression is highly variable among individuals and within the same individual at different times. Upregulation of alpha7 is systematically observed after incubation of lymphocytes with nicotine or alpha-bungarotoxin. In addition, the incubation with these drugs decreases the percentage of apoptotic cells induced by the exposure to cortisol. Our results suggest that alpha7 nAChRs are involved in the modulation of cortisol-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15710468     DOI: 10.1016/j.jneuroim.2004.11.010

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  24 in total

Review 1.  Structural basis of activation of cys-loop receptors: the extracellular-transmembrane interface as a coupling region.

Authors:  Mariana Bartos; Jeremías Corradi; Cecilia Bouzat
Journal:  Mol Neurobiol       Date:  2009-10-28       Impact factor: 5.590

2.  Nicotinic acetylcholine receptor expression and susceptibility to cholinergic immunomodulation in human monocytes of smoking individuals.

Authors:  Esmerij P van der Zanden; Francisca W Hilbers; Caroline Verseijden; Rene M van den Wijngaard; Mike Skynner; Kevin Lee; Luis Ulloa; Guy E Boeckxstaens; Wouter J de Jonge
Journal:  Neuroimmunomodulation       Date:  2012-03-21       Impact factor: 2.492

3.  Promoter methylation and tissue-specific transcription of the α7 nicotinic receptor gene, CHRNA7.

Authors:  Andrew Canastar; Judith Logel; Sharon Graw; Jessica Finlay-Schultz; Christina Osborne; Milda Palionyte; Carla Drebing; Molly Plehaty; Lisa Wilson; Rosemary Eyeson; Sherry Leonard
Journal:  J Mol Neurosci       Date:  2011-11-04       Impact factor: 3.444

4.  Up-regulation of the neuronal nicotinic receptor α7 by HIV glycoprotein 120: potential implications for HIV-associated neurocognitive disorder.

Authors:  Leomar Y Ballester; Coral M Capó-Vélez; Wilfredo F García-Beltrán; Félix M Ramos; Edwin Vázquez-Rosa; Raymond Ríos; José R Mercado; Roberto I Meléndez; José A Lasalde-Dominicci
Journal:  J Biol Chem       Date:  2011-11-14       Impact factor: 5.157

5.  Attenuation of CNS inflammatory responses by nicotine involves α7 and non-α7 nicotinic receptors.

Authors:  Junwei Hao; Alain R Simard; Gregory H Turner; Jie Wu; Paul Whiteaker; Ronald J Lukas; Fu-Dong Shi
Journal:  Exp Neurol       Date:  2010-10-13       Impact factor: 5.330

6.  Cytokine-induced alterations of α7 nicotinic receptor in colonic CD4 T cells mediate dichotomous response to nicotine in murine models of Th1/Th17- versus Th2-mediated colitis.

Authors:  Valentin Galitovskiy; Jing Qian; Alexander I Chernyavsky; Steve Marchenko; Vivian Gindi; Robert A Edwards; Sergei A Grando
Journal:  J Immunol       Date:  2011-07-22       Impact factor: 5.422

7.  Silencing A7-nAChR levels increases the sensitivity of gastric cancer cells to ixabepilone treatment.

Authors:  Chao-Chiang Tu; Chien-Yu Huang; Wan-Li Cheng; Chin-Sheng Hung; Yu-Jia Chang; Po-Li Wei
Journal:  Tumour Biol       Date:  2016-01-20

8.  Expression and Functional Role of α7 Nicotinic Receptor in Human Cytokine-stimulated Natural Killer (NK) Cells.

Authors:  Samanta R Zanetti; Andrea Ziblat; Nicolás I Torres; Norberto W Zwirner; Cecilia Bouzat
Journal:  J Biol Chem       Date:  2016-06-09       Impact factor: 5.157

Review 9.  Alpha7 nicotinic acetylcholine receptor: a link between inflammation and neurodegeneration.

Authors:  Concepcion Conejero-Goldberg; Peter Davies; Luis Ulloa
Journal:  Neurosci Biobehav Rev       Date:  2007-11-28       Impact factor: 8.989

Review 10.  The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation.

Authors:  W J de Jonge; L Ulloa
Journal:  Br J Pharmacol       Date:  2007-05-14       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.